KPTI — Karyopharm Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Karyopharm Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	262	249	229	278	191
Net Total Accounts Receivable
Net Total Receivables	7.86	12.9	22.5	47.1	27
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	279	277	276	350	234
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	13.7	11.6	9.56	7.38	4.88
Long Term Investments
Other Long Term Assets
Total Assets	295	313	305	358	240
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	46.4	60.2	73.7	65.9	69.5
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	245	263	385	375	377
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	49.8	50.5	-79.7	-16.7	-136
Total Liabilities & Shareholders' Equity	295	313	305	358	240
Total Common Shares Outstanding